The majority of small-molecule drugs that emerge from today’s discovery pipelines are too poorly water-soluble to allow for reproducible absorption after oral intake. This solubility problem dramatically complicates drug development and prevents patients from accessing potentially life-saving therapeutics.
At SeraNovo, we design, develop and GMP-manufacture solubility-enhancing formulations using our proprietary technology platform that harnesses the unique benefits of deep eutectic solvents. Our formulations are being used by pharma and biotech companies across the globe to enhance the bioavailability of compounds in discovery, development and life cycle management projects.
This website uses cookies to track the usage of it.
More info
